Product Code: GVR-4-68040-511-4
Cystoscope Market Growth & Trends:
The global cystoscope market size is anticipated to reach USD 2.17 billion by 2030 and is anticipated to expand at a CAGR of 9.99% during the forecast period, according to a new report by Grand View Research, Inc. The cystoscope market is driven by numerous factors such as technological advancements, rising number of clinical trials and growing competition among the industry players.
The increasing focus on research activities and clinical studies using cystoscopes in wide applications is anticipated to propel the market growth in the coming years. For instance, in December 2024, Medtecx Co Ltd. sponsored a clinical trial involving 126 study participants to evaluate the safety and efficacy of the water vapor thermal therapy system for treating benign prostatic hyperplasia.
Moreover, in February 2023, the Centre Hospitalier Universitaire Vaudois sponsored a clinical study to demonstrate that using a flexible cystoscope provides the same quality of urine collection for analysis as using an intermittent bladder catheter while being less uncomfortable for the patient. The study enrolled approximately 414 participants . Therefore, the growing utilization of cystoscopes in various clinical trials and studies is expected to drive market growth in the coming years.
Furthermore, the growing demand for cystoscopy procedures, driven by the increasing prevalence of urological disorders, is expected to boost market growth. A significant number of cystoscopy procedures are being conducted in both hospitals and outpatient settings. For instance, data from the MD Anderson Cancer Center published in July 2024 indicates that approximately 16 cystoscopies are performed daily, totaling over 4,000 annually. This high volume of diagnostic procedures is projected to stimulate cystoscope market growth in the coming years.
Cystoscope Market Report Highlights:
- The flexible cystoscope segment dominated the market and is expected to register the fastest CAGR of 10.93% during the forecast period, owing to novel product launches by industry key players to expand their product portfolio.
- The video cystoscope segment dominated the market and is expected to register the fastest CAGR of 10.73% during the forecast period. The increasing regulatory approvals for advanced cystoscopes, such as video cystoscopes, are supporting the segment's growth.
- The urology segment dominated the market and is expected to register the fastest CAGR of 10.56% in the coming years. The increasing prevalence of urological conditions such as urinary incontinence, urinary tract infections, and bladder cancer is anticipated to drive the segment's growth.
- The hospital segment dominated the market and accounted for the revenue share of 40.64% in 2024. On the other hand, the ambulatory surgery center segment is expected to grow with the highest CAGR in the coming years.
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.2. Research Methodology
- 1.3. Information Procurement
- 1.4. Information or Data Analysis
- 1.5. Market Formulation & Validation
- 1.6. Model Details
- 1.7. List of Data Sources
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.3. Competitive Insights
Chapter 3. Cystoscope Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.2. Market Dynamics
- 3.2.1. Market driver analysis
- 3.2.1.1. Increasing prevalence of urological & gynecological disorders
- 3.2.1.2. Technological advancements
- 3.2.1.3. Growing geriatric population
- 3.2.2. Market restraint analysis
- 3.2.2.1. High cost of advanced cystoscope products and associated treatments
- 3.2.2.2. Adverse effects and risk of complications associated with the use of cystoscopes
- 3.2.3. Market opportunity analysis
- 3.2.3.1. Increasing focus on research & development
- 3.2.3.2. Growth potential in emerging economies in cystoscope market
- 3.2.3.3. Rising number of clinical trials
- 3.2.4. Market challenge analysis
- 3.2.4.1. Growing number of product recalls
- 3.3. Cystoscope Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.1.1. Bargaining power of suppliers
- 3.3.1.2. Bargaining power of buyers
- 3.3.1.3. Threat of substitutes
- 3.3.1.4. Threat of new entrants
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political & Legal Landscape
- 3.3.2.2. Economic and Social Landscape
- 3.3.2.3. Technological landscape
Chapter 4. Cystoscope Market: Product Estimates & Trend Analysis
- 4.1. Segment Dashboard
- 4.2. Global Cystoscope Market Movement Analysis
- 4.3. Global Cystoscope Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
- 4.4. Flexible Cystoscopes
- 4.4.1. Flexible cystoscopes market estimates and forecast 2018 to 2030 (USD Million)
- 4.5. Rigid cystoscope
- 4.5.1. Rigid cystoscope market estimates and forecast 2018 to 2030 (USD Million)
Chapter 5. Cystoscope Market: Application Estimates & Trend Analysis
- 5.1. Segment Dashboard
- 5.2. Global Cystoscope Market Movement Analysis
- 5.3. Global Cystoscope Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
- 5.4. Urology
- 5.4.1. Urology market estimates and forecast 2018 to 2030 (USD Million)
- 5.5. Gynecology
- 5.5.1. Gynecology market estimates and forecast 2018 to 2030 (USD Million)
Chapter 6. Cystoscope Devices: End Use Estimates & Trend Analysis
- 6.1. Segment Dashboard
- 6.2. Global Cystoscope Market Movement Analysis
- 6.3. Global Cystoscope Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
- 6.4. Hospitals
- 6.4.1. Hospitals market estimates and forecast 2018 to 2030 (USD Million)
- 6.5. Diagnostic Imaging Centers
- 6.5.1. Diagnostic imaging centers market estimates and forecast 2018 to 2030 (USD Million)
- 6.6. Ambulatory Surgery Centers
- 6.6.1. Ambulatory surgery centers market estimates and forecast 2018 to 2030 (USD Million)
- 6.7. Others
- 6.7.1. Others market estimates and forecast 2018 to 2030 (USD Million)
Chapter 7. Cystoscope Market: Type Estimates & Trend Analysis
- 7.1. Segment Dashboard
- 7.2. Global Cystoscope Market Movement Analysis
- 7.3. Global Cystoscope Market Size & Trend Analysis, by Mode Of Purchase, 2018 to 2030 (USD Million)
- 7.4. Video Cystoscopes
- 7.4.1. Video cystoscopes market estimates and forecast 2018 to 2030 (USD Million)
- 7.5. Fiberoptic Cystoscopes
- 7.5.1. Fiberoptic cystoscopes market estimates and forecast 2018 to 2030 (USD Million)
Chapter 8. Cystoscope Market: Regional Estimates & Trend Analysis
- 8.1. Regional Dashboard
- 8.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
- 8.3. North America
- 8.3.1. Market estimates and forecast, 2018-2030 (Revenue, USD Million)
- 8.3.2. U.S.
- 8.3.2.1. Key country dynamics
- 8.3.2.2. Competitive scenario
- 8.3.2.3. Regulatory framework
- 8.3.2.4. Reimbursement scenario
- 8.3.2.5. U.S. market estimates and forecasts, 2018-2030
- 8.3.3. Canada
- 8.3.3.1. Key country dynamics
- 8.3.3.2. Competitive scenario
- 8.3.3.3. Regulatory framework
- 8.3.3.4. Reimbursement scenario
- 8.3.3.5. Canada market estimates and forecasts, 2018-2030
- 8.3.4. Mexico
- 8.3.4.1. Key country dynamics
- 8.3.4.2. Competitive scenario
- 8.3.4.3. Regulatory framework
- 8.3.4.4. Reimbursement scenario
- 8.3.4.5. Mexico market estimates and forecasts, 2018-2030
- 8.4. Europe
- 8.4.1. UK
- 8.4.1.1. Key country dynamics
- 8.4.1.2. Competitive scenario
- 8.4.1.3. Regulatory framework
- 8.4.1.4. Reimbursement scenario
- 8.4.1.5. UK market estimates and forecasts, 2018-2030
- 8.4.2. Germany
- 8.4.2.1. Key country dynamics
- 8.4.2.2. Competitive scenario
- 8.4.2.3. Regulatory framework
- 8.4.2.4. Reimbursement scenario
- 8.4.2.5. Germany market estimates and forecasts, 2018-2030
- 8.4.3. France
- 8.4.3.1. Key country dynamics
- 8.4.3.2. Competitive scenario
- 8.4.3.3. Regulatory framework
- 8.4.3.4. Reimbursement scenario
- 8.4.3.5. France market estimates and forecasts, 2018-2030
- 8.4.4. Italy
- 8.4.4.1. Key country dynamics
- 8.4.4.2. Competitive scenario
- 8.4.4.3. Regulatory framework
- 8.4.4.4. Reimbursement scenario
- 8.4.4.5. Italy market estimates and forecasts, 2018-2030
- 8.4.5. Spain
- 8.4.5.1. Key country dynamics
- 8.4.5.2. Competitive scenario
- 8.4.5.3. Regulatory framework
- 8.4.5.4. Reimbursement scenario
- 8.4.5.5. Spain market estimates and forecasts, 2018-2030
- 8.4.6. Denmark
- 8.4.6.1. Key country dynamics
- 8.4.6.2. Competitive scenario
- 8.4.6.3. Regulatory framework
- 8.4.6.4. Reimbursement scenario
- 8.4.6.5. Denmark market estimates and forecasts, 2018-2030
- 8.4.7. Sweden
- 8.4.7.1. Key country dynamics
- 8.4.7.2. Competitive scenario
- 8.4.7.3. Regulatory framework
- 8.4.7.4. Reimbursement scenario
- 8.4.7.5. Sweden market estimates and forecasts, 2018-2030
- 8.4.8. Norway
- 8.4.8.1. Key country dynamics
- 8.4.8.2. Competitive scenario
- 8.4.8.3. Regulatory framework
- 8.4.8.4. Reimbursement scenario
- 8.4.8.5. Norway market estimates and forecasts, 2018-2030
- 8.5. Asia Pacific
- 8.5.1. Japan
- 8.5.1.1. Key country dynamics
- 8.5.1.2. Competitive scenario
- 8.5.1.3. Regulatory framework
- 8.5.1.4. Reimbursement scenario
- 8.5.1.5. Japan market estimates and forecasts, 2018-2030
- 8.5.2. India
- 8.5.2.1. Key country dynamics
- 8.5.2.2. Competitive scenario
- 8.5.2.3. Regulatory framework
- 8.5.2.4. Reimbursement scenario
- 8.5.2.5. India market estimates and forecasts, 2018-2030
- 8.5.3. China
- 8.5.3.1. Key country dynamics
- 8.5.3.2. Competitive scenario
- 8.5.3.3. Regulatory framework
- 8.5.3.4. Reimbursement scenario
- 8.5.3.5. China market estimates and forecasts, 2018-2030
- 8.5.4. South Korea
- 8.5.4.1. Key country dynamics
- 8.5.4.2. Competitive scenario
- 8.5.4.3. Regulatory framework
- 8.5.4.4. Reimbursement scenario
- 8.5.4.5. South Korea market estimates and forecasts, 2018-2030
- 8.5.5. Australia
- 8.5.5.1. Key country dynamics
- 8.5.5.2. Competitive scenario
- 8.5.5.3. Regulatory framework
- 8.5.5.4. Reimbursement scenario
- 8.5.5.5. Australia market estimates and forecasts, 2018-2030
- 8.5.6. Thailand
- 8.5.6.1. Key country dynamics
- 8.5.6.2. Competitive scenario
- 8.5.6.3. Regulatory framework
- 8.5.6.4. Reimbursement scenario
- 8.5.6.5. Thailand market estimates and forecasts, 2018-2030
- 8.6. Latin America
- 8.6.1. Brazil
- 8.6.1.1. Key country dynamics
- 8.6.1.2. Competitive scenario
- 8.6.1.3. Regulatory framework
- 8.6.1.4. Reimbursement scenario
- 8.6.1.5. Brazil market estimates and forecasts, 2018-2030
- 8.6.2. Argentina
- 8.6.2.1. Key country dynamics
- 8.6.2.2. Competitive scenario
- 8.6.2.3. Regulatory framework
- 8.6.2.4. Reimbursement scenario
- 8.6.2.5. Argentina market estimates and forecasts, 2018-2030
- 8.7. MEA
- 8.7.1. South Africa
- 8.7.1.1. Key country dynamics
- 8.7.1.2. Competitive scenario
- 8.7.1.3. Regulatory framework
- 8.7.1.4. Reimbursement scenario
- 8.7.1.5. South Africa market estimates and forecasts, 2018-2030
- 8.7.2. Saudi Arabia
- 8.7.2.1. Key country dynamics
- 8.7.2.2. Competitive scenario
- 8.7.2.3. Regulatory framework
- 8.7.2.4. Reimbursement scenario
- 8.7.2.5. Saudi Arabia market estimates and forecasts, 2018-2030
- 8.7.3. UAE
- 8.7.3.1. Key country dynamics
- 8.7.3.2. Competitive scenario
- 8.7.3.3. Regulatory framework
- 8.7.3.4. Reimbursement scenario
- 8.7.3.5. UAE market estimates and forecasts, 2018-2030
- 8.7.4. Kuwait
- 8.7.4.1. Key country dynamics
- 8.7.4.2. Competitive scenario
- 8.7.4.3. Regulatory framework
- 8.7.4.4. Reimbursement scenario
- 8.7.4.5. Kuwait market estimates and forecasts, 2018-2030
Chapter 9. Competitive Landscape
- 9.1. Market Participant Categorization
- 9.2. Key Company Profiles
- 9.2.1. Olympus Corporation
- 9.2.1.1. Company overview
- 9.2.1.2. Financial performance
- 9.2.1.3. Product benchmarking
- 9.2.1.4. Strategic initiatives
- 9.2.2. Boston Scientific Corporation or its affiliates
- 9.2.2.1. Company overview
- 9.2.2.2. Financial performance
- 9.2.2.3. Product benchmarking
- 9.2.2.4. Strategic initiatives
- 9.2.3. Ambu Inc.
- 9.2.3.1. Company overview
- 9.2.3.2. Financial performance
- 9.2.3.3. Product benchmarking
- 9.2.3.4. Strategic initiatives
- 9.2.4. KARL STORZ
- 9.2.4.1. Company overview
- 9.2.4.2. Financial performance
- 9.2.4.3. Product benchmarking
- 9.2.4.4. Strategic initiatives
- 9.2.5. Advin Health Care
- 9.2.5.1. Company overview
- 9.2.5.2. Financial performance
- 9.2.5.3. Product benchmarking
- 9.2.5.4. Strategic initiatives
- 9.2.6. Intuitive Surgical (SCHOLLY FIBEROPTIC GMBH)
- 9.2.6.1. Company overview
- 9.2.6.2. Financial performance
- 9.2.6.3. Product benchmarking
- 9.2.6.4. Strategic initiatives
- 9.2.7. Stryker
- 9.2.7.1. Company overview
- 9.2.7.2. Financial performance
- 9.2.7.3. Product benchmarking
- 9.2.7.4. Strategic initiatives
- 9.2.8. UroViu Corporation
- 9.2.8.1. Company overview
- 9.2.8.2. Financial performance
- 9.2.8.3. Product benchmarking
- 9.2.8.4. Strategic initiatives
- 9.2.9. NeoScope Inc.
- 9.2.9.1. Company overview
- 9.2.9.2. Financial performance
- 9.2.9.3. Product benchmarking
- 9.2.9.4. Strategic initiatives
- 9.2.10. OTU Medical
- 9.2.10.1. Company overview
- 9.2.10.2. Financial performance
- 9.2.10.3. Product benchmarking
- 9.2.10.4. Strategic initiatives
- 9.2.11. HOYA Corporation (Pentax Medical)
- 9.2.11.1. Company overview
- 9.2.11.2. Financial performance
- 9.2.11.3. Product benchmarking
- 9.2.11.4. Strategic initiatives
- 9.3. Heat Map Analysis/ Company Market Position Analysis
- 9.4. Estimated Company Market Share Analysis, 2024
- 9.5. List of Other Key Market Players